LOS ANGELES, CA / ACCESSWIRE / May 31, 2017 / BIOLASE, Inc. (BIOL), the global leader in dental lasers, today announced that it will be presenting at the 7th annual LD Micro Invitational investor conference at 12:30 PM PDT, Wednesday, June 7, 2016. BIOLASE President and Chief Executive Officer, Harold C. Flynn, Jr., will be giving the presentation and meeting with investors.
A live webcast and a 90-day replay of the presentation will be available from LD Micro by clicking here or from BIOLASE on the Investor Events page of its website at http://www.biolase.com/Pages/Investors.aspx.
The conference will be held from June 6-7, 2017, at the Luxe Sunset Bel Air Hotel and will feature 180 small- and micro-cap companies.
In addition to a record number of companies making their LD Micro debuts this year, there are a record number of companies presenting for the first time in their company's history.
LD Micro President, Chris Lahiji, said, "We are proud to have established LD as the venue that brings a big group of the most influential players from all segments of the market together under one roof to meet with a large number of exciting and innovative small- and micro-cap companies."
To access the BIOLASE Inc. profile prepared by LD Micro, please click here: http://www.ldmicro.com/profile/BIOL
Profiles powered by LD Micro - News Compliments of ACCESSWIRE.
About BIOLASE, Inc.
BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 210 patented and 90 patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold approximately 34,200 laser systems to date in over 90 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer markets.
For updates and information on Waterlase® iPlus™, Waterlase Express™ and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, LinkedIn at www.linkedin.com/company/biolase, Instagram at www.instagram.com/biolaseinc, and YouTube at www.youtube.com/biolasevideos.